Dr. Mayock's basic research interests include evaluation of the effects of fetal and neonatal drug (alcohol, morphine) exposure on fetal, neonatal and adult cerebrovascular function. Dr. Mayock's clinical research interests include evaluation of therapies that potentially may alter the development of Bronchopulmonary Dysplasia such as inhaled nitric oxide and late surfactant treatments.
In collaboration with Drs. Juul and Gleason, he is evaluating whether high dose erythropoietin treatment has neuroprotective effects in preterm and term infants. Lastly,
Dr. Mayock is collaborating with Dr. Laura Ment at Yale University to determine whether genetic polymorphisms might explain risk of intraventricular hemorrhage in preterm infants.